To Stay: Two More Cancer Indications With ' Dangling Approvals ' To Stay: Two More Cancer Indications With ' Dangling Approvals '

On the second day of a historic meeting, FDA advisers voted to keep the accelerated approvals for two immunotherapies for use in bladder cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news